TRC 2XXX

Drug Profile

TRC 2XXX

Latest Information Update: 30 Jan 2007

Price : $50

At a glance

  • Originator Torrent Pharmaceuticals
  • Class Vasodilators
  • Mechanism of Action Nitric oxide donors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Angina pectoris

Most Recent Events

  • 10 Sep 2002 TRC 2XXX is available for licensing in the USA, Europe and Japan [http://www.torrent-india.com]
  • 10 Sep 2002 Preclinical trials in Angina pectoris in India (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top